Poor training - werkgeversreview Cytogenetic Technician bij NeoGenomics

3,0
1 apr 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Good pay for the market

Minpunten

Poor management and training, and management doesn’t seem to have planning. Safety concerns not taken seriously. Department has incredibly poor PTO system, don’t expect any for 8 months after hire.

Ontdek andere reviews over NeoGenomics

5,0
11 mrt 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Growing business opportunities for many job seekers

Minpunten

Ever changing approach on direction on projects

2,0
2 mrt 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

The workforce wants to do the right thing. We take pride in knowing our services impact people's lives everyday.

Minpunten

Constant turnover, lack of communication throughout - top to bottom. Leadership is struggling and not performing, Most of their attempts to improve growth have lost money. This is factual, not to be mistaken with statements from a disgruntled employee. An article published after the recent earnings release emphasized NEO's 5-year Return on Invested Capital is -10.5%, meaning management doesn't spend our capital wisely. This, along with heavy debt, minimal cash and returns at the bottom of the healthcare sector, should make you pause and do more research before jumping on board.

5
Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle